GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Co Ltd (ROCO:6892) » Definitions » Change In Payables And Accrued Expense

Taiwan Bio Therapeutics Co (ROCO:6892) Change In Payables And Accrued Expense : NT$0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Co Change In Payables And Accrued Expense?

Taiwan Bio Therapeutics Co's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2024 was NT$0.0 Mil. It means Taiwan Bio Therapeutics Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Jun. 2024 .

Taiwan Bio Therapeutics Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was NT$0.0 Mil. It means Taiwan Bio Therapeutics Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Taiwan Bio Therapeutics Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Taiwan Bio Therapeutics Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Co Change In Payables And Accrued Expense Chart

Taiwan Bio Therapeutics Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
- - - - -

Taiwan Bio Therapeutics Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only - - - - -

Taiwan Bio Therapeutics Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Bio Therapeutics Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Bio Therapeutics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Co Ltd (ROCO:6892) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
TPE:3164 TPE:4133 ROCO:6846 ROCO:4171 ROCO:6879 ROCO:6580 ROCO:4195 ROCO:4186 ROCO:6564 ROCO:6827 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 18, Lane 120, Hu Road, Section 1, 6th Floor, Neihu District, Taipei, TWN
Website
http://www.twbio-thera.com
Taiwan Bio Therapeutics Co Ltd is a regenerative medicine company specializing in the development of new cell medicines. It provides cell product process development and foundry (CDMO/CMO) services.

Taiwan Bio Therapeutics Co Headlines

No Headlines